T2 Biosystems to Attend Upcoming Investor Conferences
July 28 2023 - 8:30AM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens and antibiotic resistance
genes, today announced plans to participate in two upcoming
investor conferences in August 2023:
- Canaccord Genuity Annual Growth Conference in
Boston, Massachusetts. Management is scheduled to host a fireside
chat on Wednesday, August 9, 2023, at 1:00pm ET.
- Sidoti Micro-Cap Conference, virtual
participation. Management is scheduled to present on Wednesday,
August 16, 2023, at 10:00am ET.
Interested parties may access live and recorded webcasts of the
presentations on the “Investors” section of the Company’s website
at www.t2biosystems.com.
About T2 Biosystems:T2
Biosystems, a leader in the rapid detection of sepsis-causing
pathogens and antibiotic resistance genes, is dedicated to
improving patient care and reducing the cost of care by helping
clinicians effectively treat patients faster than ever before. T2
Biosystems’ products include the T2Dx® Instrument, the T2Bacteria®
Panel, the T2Candida® Panel, the T2Resistance® Panel, and the
T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic
Resonance (T2MR®) technology. T2 Biosystems has an active pipeline
of future products, including the T2Biothreat™ Panel, the Candida
auris test, and T2Lyme™ Panel, as well as next-generation products
for the detection of bacterial and fungal pathogens and associated
antimicrobial resistance markers. For more information, please
visit www.t2biosystems.com.
Investor Contact:Philip Trip Taylor, Gilmartin
Groupphilip@gilmartinIR.com 415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2024 to May 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From May 2023 to May 2024